Trang, N.N.; Chung, C.-C.; Lee, T.-W.; Cheng, W.-L.; Kao, Y.-H.; Huang, S.-Y.; Lee, T.-I.; Chen, Y.-J.
Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats. Int. J. Mol. Sci. 2021, 22, 1177.
https://doi.org/10.3390/ijms22031177
AMA Style
Trang NN, Chung C-C, Lee T-W, Cheng W-L, Kao Y-H, Huang S-Y, Lee T-I, Chen Y-J.
Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats. International Journal of Molecular Sciences. 2021; 22(3):1177.
https://doi.org/10.3390/ijms22031177
Chicago/Turabian Style
Trang, Nguyen Ngoc, Cheng-Chih Chung, Ting-Wei Lee, Wan-Li Cheng, Yu-Hsun Kao, Shih-Yu Huang, Ting-I Lee, and Yi-Jen Chen.
2021. "Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats" International Journal of Molecular Sciences 22, no. 3: 1177.
https://doi.org/10.3390/ijms22031177
APA Style
Trang, N. N., Chung, C.-C., Lee, T.-W., Cheng, W.-L., Kao, Y.-H., Huang, S.-Y., Lee, T.-I., & Chen, Y.-J.
(2021). Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats. International Journal of Molecular Sciences, 22(3), 1177.
https://doi.org/10.3390/ijms22031177